Benzidine Induces Epithelial-Mesenchymal Transition of Human Bladder Cancer Cells through Activation of ERK5 Pathway.
Sun X, Zhang T, Deng Q, Zhou Q, Sun X, Li E, Yu D, Zhong C.
Mol Cells. 2018 Mar 31;41(3):188-197. doi: 10.14348/molcells.2018.2113. Epub 2018 Feb 21.
PMID:29463068
N-glucuronidation of benzidine and its metabolites. Role in bladder cancer.
Zenser TV, Lakshmi VM, Davis BB.
Drug Metab Dispos. 1998 Sep;26(9):856-9.
PMID:9733663
Occupational reproductive function abnormalities and bladder cancer in Korea.
Park J, Shin KS, Kim Y.
J Korean Med Sci. 2010 Dec;25(Suppl):S41-5. doi: 10.3346/jkms.2010.25.S.S41. Epub 2010 Dec 15.
PMID:21258590
MAPK/AP-1 pathway regulates benzidine-induced cell proliferation through the control of cell cycle in human normal bladder epithelial cells.
Zhao L, Zhang T, Geng H, Liu ZQ, Liang ZF, Zhang ZQ, Min J, Yu DX, Zhong CY.
Oncol Lett. 2018 Oct;16(4):4628-4634. doi: 10.3892/ol.2018.9155. Epub 2018 Jul 17.
PMID:30197677
Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
Liu Z, Liu J, Zhao L, Geng H, Ma J, Zhang Z, Yu D, Zhong C.
Int J Oncol. 2017 Apr;50(4):1321-1329. doi: 10.3892/ijo.2017.3887. Epub 2017 Feb 21.
PMID:28259934
Reply to the letter to the Editor: "N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis".
Carreón T, Kadlubar FF, Ruder AM, Schulte PA, Hayes RB, Waters M, Grant DJ, Boissy R, Bell DA, Hemstreet GP 3rd, Yin S, Lemasters GK, Rothman N.
Int J Cancer. 2007 Oct 1;121(7):1637-9; author reply 1640-1. doi: 10.1002/ijc.22906.
PMID:17583575
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
Liu Z, Liu J, Zhao L, Geng H, Ma J, Zhang Z, Yu D, Zhong C.
Int J Oncol. 2023 Jul;63(1):85. doi: 10.3892/ijo.2023.5533. Epub 2023 Jun 16.
PMID:37326030
N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis.
Wang CY, King CM.
Int J Cancer. 2007 Jun 1;120(11):2523-4. doi: 10.1002/ijc.22638.